QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.113290v1 321/1/227    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Li, J.-X. Articles by France, C. P. Search for Related Content PubMed PubMed Citation Articles by Li, J.-X. Articles by France, C. P.

BEHAVIORAL PHARMACOLOGY

Thienorphine: Receptor Binding and Behavioral Effects in Rhesus Monkeys

Departments of Pharmacology (J.-X.L., G.L.B., C.P.F.) and Psychiatry (C.P.F.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan (J.R.T.); and Department of Pharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, People's Republic of China (Z.-H.G.)

Thienorphine is an oripavine with long-lasting antinociceptive effects in mice that are thought to be mediated by µ-opioid receptors. This study examined the receptor binding of thienorphine in cell membrane homogenates and its behavioral effects in rhesus monkeys (Macaca mulatta). Affinity and potency were determined using radioligand displacement and stimulation of guanosine 5'-O-(3-[³⁵S]thio)triphosphate binding in C6 (µ, ) and Chinese hamster ovary () cell membranes. Thienorphine displayed high affinity for -, µ-, and -opioid receptors with K_i values of 0.14, 0.22, and 0.69 nM, respectively. Thienorphine partially stimulated -opioid (75%) and µ-opioid (19%) receptors and not -opioid receptors. Thienorphine dose-dependently increased tail-withdrawal latency for 50°C water and not 55°C water with effects lasting for more than 7 days. The -opioid receptor antagonist nor-binaltorphimine (nor-BNI) (3.2 mg/kg) and a large dose (1.0 mg/kg) of naltrexone prevented thienorphine-induced antinociception. Thienorphine enhanced the antinociceptive effects of morphine and U50,488 [trans-3, 4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamide] with 50°C water; with 55°C water, thienorphine enhanced the effects of morphine and attenuated the effects of U50,488. In other monkeys, thienorphine decreased responding in both components of a multiple schedule of food presentation and stimulus shock termination for up to 8 days; naltrexone and nor-BNI partially prevented these rate-decreasing effects. In morphine-treated monkeys discriminating naltrexone, thienorphine, and U50,488 neither substituted for nor modified the naltrexone discriminative stimulus. Thienorphine and U50,488 produced the same directly observable signs. These results show that thienorphine has long-lasting effects that seem to be mediated by low-efficacy agonism at -opioid receptors, both in vitro and in vivo.

Address correspondence to: Dr. Charles P. France, Department of Pharmacology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Mail Code 7792, San Antonio, TX 78229-3900. E-mail: france{at}uthscsa.edu